Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05627388

Feasibility Study of At-Home EEG Monitoring for Hypersomnia

Conditions: Hypersomnia, Narcolepsy

Sex: All
Ages: 6 Years – N/A
Healthy volunteers: 1
Phase: NA
Enrollment: 20
Sponsor: Kaiser Permanente

Summary

The central hypothesis is that home EEG monitoring (Dream 3 wearable) can be feasibly utilized for data capture of continuous sleep and wake measurements for the diagnostic evaluation and treatment monitoring of hypersomnia.

Eligibility Criteria

Inclusion Criteria:Patients must be a Kaiser Permanente memberPatients must be ≥ 6 years old.Patients must have an indication for Multiple Sleep Latency Test for a diagnosis of hypersomniaPatients are able/willing to consent and willing to undergo the electrophysiological routine assessments described in the protocolPatients do not meet any exclusion criteriaExclusion Criteria:Patients under 6 years old.If a patient is taking a wake promoting medication and is unsafe to withdraw the medication during the 2 weeks prior to the in-lab Polysomnography/Multiple Sleep Latency studyPatients suffering from mental and/or physical disorders that could interfere with the study protocol or the interpretation of the results (exclusion based on clinical judgment)Shift workers or patients working unusual hours will be excludedPatients not able to sign an informed consent form

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05627388). StuddyBuddy aggregates publicly available trial information.